Newsroom

csrxp

CSRxP Calls for Action on CREATES Act

CSRxP Calls for Action on CREATES Act The Campaign for Sustainable Rx Pricing released this statement from spokesman Will Holley on today’s House Judiciary Subcommittee on […]

Read more
csrxp

CSRxP Calls for Further Action on Rx Prices

CSRxP spokesman Will Holley releases statement following House passage of FDA user fee legislation.

Read more

CSRxP Releases Powerful Testimonial: “Debbie’s Story”

CSRxP Releases Powerful Testimonial: “Debbie’s Story”   The Campaign for Sustainable Rx Pricing has released a powerful testimonial from Debbie, a Georgia resident, whose prescription drug bill […]

Read more
The Right

CSRxP Highlights Big Pharma’s Price Gouging Tactics With New Spot: “The Right”

“The Right” highlights examples of Big Pharma’s price-gouging tactics, such as Miacalcin’s 3,200% price hike, Daraprim’s 5,000% price hike, and doxycycline’s 9,000% price increase in just six months. These price hikes are part of a longstanding pattern that show no sign of slowing down – in fact, a recent report showed that there were more price hikes in the first quarter of 2017 than there were in the first quarter of 2016.

Read more